Nasal nitric oxide, the guardian of paranasal sinuses, is paradoxically increased by high doses of intravenous glucocorticoids

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 10, 2005, Pages 1323-1326

  Degano, Bruno ^a,b   Tetu L ^a   Serrano, E ^a   Didier, A ^a   Arnal, J F ^b  

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b CHU RANGUEIL   (France)

Author keywords

Epithelium; Nitric oxide

Indexed keywords

GLUCOCORTICOID; INDUCIBLE NITRIC OXIDE SYNTHASE; METHYLPREDNISOLONE; NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; DOWN REGULATION; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; NOSE; PARANASAL SINUS; PRIORITY JOURNAL;

ADULT; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; METHYLPREDNISOLONE; MULTIPLE SCLEROSIS; NASAL MUCOSA; NITRIC OXIDE;

EID: 24744434928     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00880.x     Document Type: Article

References (18)

1. Dykewicz MS. 7. Rhinitis and sinusitis. J Allergy Clin Immunol 2003;111:S520-S529.
2. Keegan BM, Noseworthy JH. Multiple sclerosis. Annu Rev Med 2002;53:285-302.
3. Kunz D, Walker G, Eberhardt W, Pfeilschifter J. Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc Natl Acad Sci U S A 1996;93:255-259.
4. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci U S A 2000;97:8841-8848.
5. Lundberg JO, Farkas-Szallasi T, Weitzberg E et al. High nitric oxide production in human paranasal sinuses. Nat Med 1995;1:370-373.
6. Deja M, Busch T, Bachmann S et al. Reduced nitric oxide in sinus epithelium of patients with radiologic maxillary sinusitis and sepsis. Am J Respir Crit Care Med 2003;168:281-286.
7. Lewandowski K, Busch T, Lohbrunner H et al. Low nitric oxide concentrations in exhaled gas and nasal airways of mammals without paranasal sinuses. J Appl Physiol 1998;85:405-410.
8. Arnal JF, Flores P, Rami J et al. Nasal nitric oxide concentration in paranasal sinus inflammatory diseases. Eur Respir J 1999;13:307-312.
9. Lundberg JO, Weitzberg E, Rinder J et al. Calcium-independent and steroid-resistant nitric oxide synthase activity in human paranasal sinus mucosa. Eur Respir J 1996;9:1344-1347.
10. Pujols L, Mullol J, Torrego A, Picado C. Glucocorticoid receptors in human airways. Allergy 2004;59:1042-1052.
11. Pasto M, Serrano E, Urocoste E et al. Nasal polyp-derived superoxide anion: dose-dependent inhibition by nitric oxide and pathophysiological implications. Am J Respir Crit Care Med 2001;163:145-151.
12. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis: a prospective, randomised, controlled trial. Laryngoscope 2004;114:923-930.
13. Colantonio D, Brouillette L, Parikh A, Scadding GK. Paradoxical low nasal nitric oxide in nasal polyposis. Clin Exp Allergy 2002;32:698-701.
14. Weitzberg E, Lundberg JO. Humming greatly increases nasal nitric oxide. Am J Respir Crit Care Med 2002;166:144-145.
15. Jacobs AT, Ignarro LJ. Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J Biol Chem 2001;276:47950-47957.
16. Guthikonda P, Baker J, Mattson DH. Interferon-beta-1-b (IFN-B) decreases induced nitric oxide (NO) production by a human astrocytoma cell line. J Neuroimmunol 1998;82:133-139.
17. Hua LL, Liu JS, Brosnan CF, Lee SC. Selective inhibition of human glial inducible nitric oxide synthase by interferon-beta: implications for multiple sclerosis. Ann Neurol 1998;43:384-387.
18. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A 1990;87:10043-10047.